slider6

slider6

slide5

slide5

slide4

slide4

slide3

slide3

slide2

slide2

slide1

slide1

 

Malaysian Statistics on Medicines 2008

Home : Publications : Statistic on Medicine : Malaysian Statistics on Medicine 2008
In this chapter, we report the national estimates for use of medicines in Malaysia from the National Medicines Use Survey 2008. Statistics for the most commonly used medicines by therapeutic group and by drugs are shown in the tables below. Detailed statistics for all drugs are given in other chapters for specific therapeutic groups. Relevant 2007 statistics are tabulated to facilitate comparison with 2008 utilisation

 

…………………………………………………………………………………………………………………………………………………………………………………………………….


In this chapter, we report the national estimates for use of medicines in Malaysia from the National Medicines Use Survey 2008. Statistics for the most commonly used medicines by therapeutic group and by drugs are shown in the tables below. Detailed statistics for all drugs are given in other chapters for specific therapeutic groups. Relevant 2007 statistics are tabulated to facilitate comparison with 2008 utilisation. As in previous years, the National Medicines Use Survey (NMUS) 2008 included only drugs which were prescription medicines; Over-the-Counter

(OTC) medicines, traditional and complimentary medicines which were not controlled drugs were excluded.
The unit of measure adopted for utilisation estimates in this report is the Defined Daily Doses (DDDs) according to the World Health Organisation (WHO) Anatomical Therapeutic Chemical (ATC) classification and DDD assignment system1; the statistics are expressed as number of DDDs per 1000 population per day. This report, the Malaysian Statistics on Medicines (MSOM) 2008, covers mainly medicines which have WHOassigned DDDs. However, statistics for several classes of drugs which do not have WHO-assigned DDDs, i.e.Antineoplastics, Dermatologicals, Ophthalmologicals, Otologicals, Cough & Cold preparations and Vaccines, are also reported in the respective chapters using DDDs assigned locally, based on WHO Guidelines.

In this chapter, only drugs with WHO assigned DDDs are presented in ranking tables for therapeutic groups and individual drugs, to enable comparison with other countries.

There have not been many changes over the two year period for the top 10 therapeutic groups of drugs utilised, except antibacterials for systemic use have moved into the top 10 list whilst antithrombotic agents were no longer in the top 10 therapeutic groups utilised in 2008.

Among the therapeutic groups, drugs used in diabetes (ATC code A10) were still the highest in terms of utilisation in Malaysia for the year 2008 (Table 1.1) as was in 2007 (Table 1.2). An estimate of 4.67% of the Malaysian population was on drugs from this therapeutic group.

The therapeutic groups used for cardiovascular disorders, namely agents acting on the renin angiotensin system (C09) were consumed by 2.88% of the population, calcium channel blockers (C08) 2.61%, beta blocking agents (C07) 2.27%, lipid modifying agents (C10) 1.63%, and diuretics by 1.44%. These groups ranked from 2nd to 6th respectively (Table 1.1). However, it is noted that the utilisation of the beta-blocking agents was less in 2008 compared to 2007.

Antiinflammatory and Antirheumatic medicines constituted the next highest ranking group of drugs. However, there was a notable 11.3% reduction in total utilisation for 2008 (11.22 DDD/1000 population/day) compared to 2007 (12.66 DDD/1000 population/day). It was also clearly shown that the private sector utilisation of anti-inflammatory and antirheumatic drugs were more than double that of the public sector in both years. Both sectors showed reduction in usage in 2008 compared to 2007.


Subscribe Newsletter



ARE YOU PART OF NHSI ?

The NHSI is no doubt one of the most important healthcare statistics initiatives in Malaysia. All are welcome to join the NHSI in any capacity, whether as a Source Data Provider, Clinical Service Reference Group member, researcher, or even work part or full time in the NHSI project team.
© 2013 NATIONAL HEALTHCARE STATISTICS INITIATIVE. All Right Reserved.

NHSI data was collected based on the key-user needs for local health service research. Other users should understand that the inclusion and exclusion criteria, service and data definition used may differ from other sources. Therefore, interpretation and comparison should be made with caution.
The Health Informatics Centre, Ministry of Health Malaysia is the official source of Malaysia health data. Harmonization of health data for the purpose of International exercise must be obtained from this official source.